Mcdonald Partners LLC Atreca, Inc. Transaction History

Mcdonald Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$1.56 - $3.25 $3,900 - $8,125	-2,500 Reduced 18.94%	10,700 $19,000
Q1 2022 Apr 29, 2022	BUY	$1.61 - $5.2 $21,252 - $68,640	13,200 New	13,200 $42,000
Q4 2021 Jan 31, 2022	SELL	$2.87 - $6.29 $101,885 - $223,295	-35,500 Closed	0 $0
Q3 2021 Nov 24, 2021	SELL	$4.91 - $9.07 $1,841 - $3,401	-375 Reduced 1.05%	35,500 $221,000
Q3 2021 Oct 28, 2021	SELL	$4.91 - $9.07 $613 - $1,133	-125 Reduced 0.35%	35,875 $224,000
Q2 2021 Nov 24, 2021	SELL	$7.82 - $13.8 $2,932 - $5,175	-375 Reduced 1.03%	36,000 $307,000
Q2 2021 Jul 23, 2021	BUY	$7.82 - $13.8 $104,592 - $184,575	13,375 Added 58.15%	36,375 $310,000
Q1 2021 Nov 24, 2021	SELL	$13.0 - $19.34 $4,875 - $7,252	-375 Reduced 1.6%	23,000 $353,000
Q1 2021 Apr 15, 2021	SELL	$13.0 - $19.34 $47,125 - $70,107	-3,625 Reduced 13.43%	23,375 $358,000
Q4 2020 Feb 16, 2021	BUY	$13.03 - $17.09 $351,810 - $461,430	27,000 New	27,000 $436,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Mcdonald Partners LLC with notifications on news.